Latest filing published 20 Nov 2018 for Emmaus Life Sciences, Inc., €173k.
Insider track record
No signal scores available.
RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus podfond, RSJ Investment SICAV a.s.: trading record in brief
RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus podfond, RSJ Investment SICAV a.s. discloses dealings in Emmaus Life Sciences, Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 19 September 2017 to 8 October 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 21 November 2018: a share grant of €173k, in Emmaus Life Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus podfond, RSJ Investment SICAV a.s.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ◆198,720 USD0SEC144,000 shares@ US$1.38COMMON STOCKSEC:0001615774-18-013075:0
- ◆500,000 USD0SEC270,270 shares@ US$1.85COMMON STOCKSEC:0001615774-18-010497:0
- ◆10,215 USD0SEC4,500 shares@ US$2.27Common StockSEC:0001615774-18-004584:0
- 12,000 shares0Common StockSEC:0001615774-17-005313:0
4 of 4 declarations